Date published: 2026-5-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

5-BDBD (CAS 768404-03-1)

0.0(0)
Write a reviewAsk a question

See product citations (1)

Alternate Names:
5-(3-Bromophenyl)-1,3-dihydro-2H-benzofuro[3,2-e]-1,4-diazepin-2-one
Application:
5-BDBD is a potent P2X4 receptor antagonist
CAS Number:
768404-03-1
Molecular Weight:
355.19
Molecular Formula:
C17H11BrN2O2
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
Available in US only.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

5-BDBD is a chemical compound that functions as a selective antagonist at the serotonin 5-HT6 receptor. It acts by binding to the 5-HT6 receptor and inhibiting its activation by serotonin, thereby blocking the receptor′s downstream signaling pathways. Its ability to modulate the activity of the 5-HT6 receptor without affecting other serotonin receptors makes 5-BDBD a compound for investigating the specific functions of the 5-HT6 receptor in experimental models.


5-BDBD (CAS 768404-03-1) References

  1. Painful purinergic receptors.  |  Donnelly-Roberts, D., et al. 2008. J Pharmacol Exp Ther. 324: 409-15. PMID: 18042830
  2. Investigation of the inhibitory effects of the benzodiazepine derivative, 5-BDBD on P2X4 purinergic receptors by two complementary methods.  |  Balázs, B., et al. 2013. Cell Physiol Biochem. 32: 11-24. PMID: 23867750
  3. P2X4 receptor regulates alcohol-induced responses in microglia.  |  Gofman, L., et al. 2014. J Neuroimmune Pharmacol. 9: 668-78. PMID: 25135400
  4. Synthesis and preliminary biological evaluation of radiolabeled 5-BDBD analogs as new candidate PET radioligands for P2X4 receptor.  |  Wang, M., et al. 2017. Bioorg Med Chem. 25: 3835-3844. PMID: 28554730
  5. P2X4 Receptor Function in the Nervous System and Current Breakthroughs in Pharmacology.  |  Stokes, L., et al. 2017. Front Pharmacol. 8: 291. PMID: 28588493
  6. 5-BDBD ameliorates an OVA-induced allergic asthma by the reduction of Th2 cytokines production.  |  Hu, B., et al. 2018. Iran J Basic Med Sci. 21: 364-369. PMID: 29796218
  7. Microglia P2X4R-BDNF signalling contributes to central sensitization in a recurrent nitroglycerin-induced chronic migraine model.  |  Long, T., et al. 2020. J Headache Pain. 21: 4. PMID: 31937253
  8. Neuroprotective and neuro-rehabilitative effects of acute purinergic receptor P2X4 (P2X4R) blockade after ischemic stroke.  |  Srivastava, P., et al. 2020. Exp Neurol. 329: 113308. PMID: 32289314
  9. Structural Basis of the Negative Allosteric Modulation of 5-BDBD at Human P2X4 Receptors.  |  Bidula, S., et al. 2022. Mol Pharmacol. 101: 33-44. PMID: 34718224
  10. The mechanism by which ATP regulates alcoholic steatohepatitis through P2X4 and CD39.  |  Xia, GQ., et al. 2022. Eur J Pharmacol. 916: 174729. PMID: 34973190
  11. Acupuncture relieves the visceral pain of diarrhea-predominant irritable bowel syndrome rats by regulating P2X4 expression.  |  Tang, HY., et al. 2022. Am J Transl Res. 14: 5563-5573. PMID: 36105029
  12. Blocking P2X4 purinergic receptor attenuates alcohol-related liver fibrosis by inhibiting hepatic stellate cell activation through PI3K/AKT signaling pathway.  |  Li, ZX., et al. 2022. Int Immunopharmacol. 113: 109326. PMID: 36252487
  13. Modulation of P2X4 receptor activity by ivermectin and 5-BDBD has no effect on the development of ARPKD in PCK rats.  |  Xu, B., et al. 2022. Physiol Rep. 10: e15510. PMID: 36353932

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

5-BDBD, 5 mg

sc-290784
5 mg
$134.00
US: Only available in the US

5-BDBD, 25 mg

sc-290784A
25 mg
$508.00
US: Only available in the US